Valuation : Jagsonpal Pharmaceuticals Limited

Market Cap 12.32B 129M 111M 104M 95.06M 179M 180M 1.23B 477M 6.22B 485M 475M 20.59B P/E 2024
32.7x
P/E 2025 26.4x
Enterprise Value 11.13B 117M 100M 93.99M 85.85M 162M 163M 1.11B 431M 5.61B 438M 429M 18.59B EV / Sales 2024
2.84x
EV / Sales 2025 4.92x
Free-Float
23.94%
Yield 2024
1.81%
Yield 2025 1.15%
1 day-2.15%
1 week+2.91%
Current month+2.68%
1 month+3.21%
3 months+14.00%
6 months+40.52%
Current year+23.04%
1 week 229.54
Extreme 229.54
248
1 month 217.18
Extreme 217.18
263.7
Current year 155
Extreme 155
264.5
1 year 155
Extreme 155
264.5
3 years 109.44
Extreme 109.44
328.04
5 years 49.2
Extreme 49.2
328.04
10 years 6.5
Extreme 6.5
328.04
Manager TitleAgeSince
Chief Executive Officer 59 16/07/2022
Director of Finance/CFO - 07/10/2025
Chief Operating Officer - 04/09/2025
Director TitleAgeSince
Chairman 69 04/12/2013
Chairman 54 16/07/2022
Director/Board Member - 29/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%+2.91%+1.34%+41.94% 167M
-1.07%-7.10%+61.60%+114.83% 1,060B
-2.01%-1.25%+52.98%+62.41% 651B
-1.64%-1.15%+26.18%+79.22% 465B
-1.56%-2.12%+38.58%+40.42% 365B
-2.00%-0.87%+22.81%+38.45% 300B
-0.96%+0.85%+2.36%+12.48% 258B
-1.04%-0.46%+52.06%+71.75% 238B
-3.28%-0.39%-17.30%-54.37% 210B
-0.90%+0.33%+29.05%+92.67% 184B
Average -1.54%-0.08%+26.97%+49.98% 373.06B
Weighted average by Cap. -1.30%-2.15%+39.56%+67.37%

Financials

2024 2025
Net sales 2.09B 21.88M 18.78M 17.63M 16.1M 30.38M 30.53M 209M 80.85M 1.05B 82.16M 80.38M 3.49B 2.69B 28.17M 24.18M 22.7M 20.73M 39.12M 39.31M 269M 104M 1.36B 106M 103M 4.49B
Net income 225M 2.36M 2.02M 1.9M 1.73M 3.27M 3.29M 22.45M 8.7M 113M 8.84M 8.65M 375M 554M 5.8M 4.98M 4.68M 4.27M 8.06M 8.1M 55.34M 21.45M 279M 21.79M 21.32M 925M
Net Debt -1.39B -14.57M -12.51M -11.74M -10.72M -20.24M -20.33M -139M -53.84M -701M -54.72M -53.53M -2.32B -1.19B -12.53M -10.75M -10.09M -9.22M -17.4M -17.48M -119M -46.29M -603M -47.04M -46.02M -2B
Logo Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
Employees
1,399
Date Price Change Volume
27/08/26 236.99 -2.15% 66,137
26/08/26 ₹242.20 +0.32% 76,102
25/08/26 ₹241.43 +0.27% 44,621
24/08/26 ₹240.77 +1.79% 219,001
21/08/26 ₹236.54 +1.52% 92,791
  1. Stock Market
  2. Stocks
  3. JAGSNPHARM Stock